This low HSC toxicity is supported by our experiments, as we observed an EC50 > 3000 ng/mL in non-CML CD34+ cells (897 ng/mL in combination with 2 μM IM). This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.